首页> 外文期刊>Biochemical and Biophysical Research Communications >Intracoronary artery transplantation of cardiomyoblast-like cells from human adipose tissue-derived multi-lineage progenitor cells improve left ventricular dysfunction and survival in a swine model of chronic myocardial infarction
【24h】

Intracoronary artery transplantation of cardiomyoblast-like cells from human adipose tissue-derived multi-lineage progenitor cells improve left ventricular dysfunction and survival in a swine model of chronic myocardial infarction

机译:来自人脂肪组织衍生的多血管祖细胞的心肌细胞样细胞的颅内动脉移植改善慢性心肌梗死的猪模型中的左心室功能障碍和存活

获取原文
获取原文并翻译 | 示例
           

摘要

Transplantation of human cardiomyoblast-like cells (hCLCs) from human adipose tissue-derived multi-lineage progenitor cells improved left ventricular function and survival of rats with myocardial infarction. Here we examined the effect of intracoronary artery transplantation of human CLCs in a swine model of chronic heart failure. Twenty-four pigs underwent balloon-occlusion of the first diagonal branch followed by reperfusion, with a second balloon-occlusion of the left ascending coronary artery 1. week later followed by reperfusion. Four weeks after the second occlusion/reperfusion, 17 of the 18 surviving animals with severe chronic MI (ejection fraction <35% by echocardiography) were immunosuppressed then randomly assigned to receive either intracoronary artery transplantation of hCLCs hADMPCs or placebo lactic Ringer's solution with heparin. Intracoronary artery transplantation was followed by the distribution of DiI-stained hCLCs into the scarred myocardial milieu. Echocardiography at post-transplant days 4 and 8. weeks showed rescue and maintenance of cardiac function in the hCLCs transplanted group, but not in the control animals, indicating myocardial functional recovery by hCLCs intracoronary transplantation. At 8. week post-transplantation, 7 of 8 hCLCs transplanted animals were still alive compared with only 1 of the 5 control (p=0.0147). Histological studies at week 12 post-transplantation demonstrated engraftment of the pre DiI-stained hCLCs into the scarred myocardium and their expression of human specific alpha-cardiac actin. Human alpha cardiac actin-positive cells also expressed cardiac nuclear factors; nkx2.5 and GATA-4. Our results suggest that intracoronary artery transplantation of hCLCs is a potentially effective therapeutic strategy for future cardiac tissue regeneration.
机译:从人脂肪组织衍生的多血管祖细胞移植人心肌细胞样细胞(HCLC)的多谱系祖细胞改善了左心室功能和对心肌梗死的大鼠的存活率。在这里,我们检查了人类Clcs在慢性心力衰竭猪模型中的颅内动脉移植的影响。二十四头猪接受了第一个对角线分支的球囊闭塞,然后再灌注,左上升冠状动脉的第二个球囊闭塞。一周后,再灌注。第二次闭塞/再灌注后四周,18个具有严重慢性Mi的存活动物中的17例(通过超声心动图<35%)被免疫抑制然后随机分配,以接受HCLCS HCLCs HOSMPC或安慰剂乳液林纳溶液用肝素的溶液。颅内动脉移植随后将DII染色的HCLC分布到疤痕心肌内部环境中。在移植后的时期4和8.周的超声心动图显示HCLC移植组中的心脏功能的抢救和维持,但不在对照动物中,表明通过HCLCS骨髓移植进行心肌功能恢复。在8.周后移植后,8个HCLC移植动物仍然活着,而5对照中只有1(p = 0.0147)。第12周的组织学研究移植后,将前染色的HCLC的植入植入患有疤痕的心肌及其对人体特异性α-心脏肌动蛋白的表达。人α心脏肌动蛋白阳性细胞也表达了心脏核因素; NKX2.5和GATA-4。我们的研究结果表明,HCLC的颅内动脉移植是未来心脏组织再生的潜在有效的治疗策略。

著录项

  • 来源
  • 作者单位

    The Center for Medical Engineering and Informatics Osaka University 2-2 Yamada-oka Suita Osaka;

    Department of Somatic Stem Cell Therapy and Health Policy Institute of Biomedical Research and;

    Department of Somatic Stem Cell Therapy and Health Policy Institute of Biomedical Research and;

    Department of Surgery Osaka University Graduate School of Medicine 2-2 Yamada-oka Suita Osaka;

    Department of Surgery Osaka University Graduate School of Medicine 2-2 Yamada-oka Suita Osaka;

    Division of Biostatistics Hyogo College of Medicine 1-1 Mukogawa-cho Nishinomiya Hyogo 663-8501;

    Department of Plastic Surgery Kobe University Hospital 7-5-2 Kusunoki-cho Chuo-ku Kobe Hyogo;

    The Center for Medical Engineering and Informatics Osaka University 2-2 Yamada-oka Suita Osaka;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 生物化学;
  • 关键词

    ADMPCs; Cellular cardiomyoplasty; Myocardial infarction; Transplantation;

    机译:DEMPCS;细胞心肌成形术;心肌梗塞;移植;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号